Mr. Speaker, I rise today to announce that I am today introducing the Ovarian Cancer and Research Amendments of 2001. I am proud to be joined by 56 original co-sponsors and would like to invite the rest of my colleagues to join me in support of the bill.
Ovarian cancer is the most lethal cancer of the female reproductive system, primarily because it is so difficult to detect in its early stages. While survival rates are quite high if the disease is found before it spread beyond the ovaries, the five-year survival rate drops to 28% for women who are diagnosed and treated in the later stages of the disease. Only 25% of ovarian cancer cases are caught in the earliest stages.
The Ovarian Cancer and Research Amendments of 2001 have three components. First, it authorizes $150 million for ovarian cancer research: one- half to be spent on basic cancer research and one-half on clinical trials and treatment. The bill requires that priority be given to developing a test for the early detection of ovarian cancer; research to identify precursor lesions and to determine the manner in which benign conditions progress to malignant status; and research to determine the relationship between ovarian cancer and endometriosis. Moreover, the bill requires that appropriate counseling be provided to women participating in clinical trials. Second, the bill provides for a comprehensive education program to provide information to patients and the public on screening procedures, the genetic basis to ovarian cancer, factors that increase the risk of getting ovarian cancer; and any new treatments for ovarian cancer. Finally, it requires that the National Cancer Advisory Board include at least one individual who is at high risk of developing ovarian cancer. I hope all my colleagues will join me in supporting this worthy cause and help to give women a fighting chance against ovarian cancer.
What is the price of Imatinib in India
The Cancer Research Initiatives Foundation (CARIF) is the first independent Malaysian fundamental cancer research organization. We seek an understanding of the genetic basis of cancers in Malaysia through molecular analysis. The specific projects are described below:
High-carb diets may increase more than just waistlines. New research suggests they might raise the risk of breast cancer. Women in Mexico who ate a lot of carbohydrates were more than twice as likely to get breast cancer than those who ate less starch and sugar, scientists found. The study is hardly the last word on the subject, but it is one of the few to examine how the popular but controversial low-carb diet craze might affect the odds of getting cancer, as opposed to its effects on cholesterol and heart disease. The new findings also don’t mean that it is safe or healthful to eat lots of meat, cheese or fats, as many people who go on low-carb diets do, experts say.
It is almost a year since I have come to this ng. You heard many times how I verify all I hear, read. Not long ago, there was a research done in Europe which said that the most single reason for cancer in human is lack of respect we experience in our lives. Looking at the people whom I knew, looking into my experiences it stroked me as something very probable.
COMPANY
BACKGROUND: Harvard researchers reported in a 2002 article in the Journal of the National Cancer Institute that eating tomato products on a regular basis is associated with a reduced risk of prostate cancer. The research included more than 47,000 participants. Researchers then continued to follow the men for several more years to learn more about the specific foods that seem to protect men from prostate cancer. That research was published this year — also in the Journal of the National Cancer Institute. The study reports men who ate tomato sauce at least twice a week were about 20-percent less likely to develop prostate cancer when compared to men who rarely ate it.
Associated Press
Mr. LAZIO. Mr. Speaker, I rise to introduce the bill entitled the Breast Cancer Research Stamps Reauthorization Act of 2000.
PHILADELPHIA Subtle differences in the receptor for vitamin D reverse the anti-cancer action of the sunshine vitamin, increasing the risk of breast cancer in Caucasian women and prostate cancer in African-American men, according to two new studies. The results, in journals published by the American Association for Cancer Research, underscore how naturally-occurring variants of the same gene, called polymorphisms, can have implications for cancer initiation and progression.


